You are here

Circassia

A bruised Circassia offloads debt by returning COPD drugs to AstraZeneca

Endpoints

Thu, 04/9/20 - 10:37 am

COPD space about to have another drug

Bizjournals

Thu, 04/18/19 - 09:47 am

Duaklir Pressair

Circassia gets dual boost for US COPD drugs

Pharmaforum

Mon, 04/1/19 - 10:39 am

Four years after mega IPO, Circassia set for small-cap exchange

Fierce Biotech

Tue, 12/11/18 - 10:24 am

A final flop signals the bitter end to Circassia’s big plans for allergy R&D

Endpoints

Tue, 04/18/17 - 09:34 am

$230M deal: AstraZeneca forms COPD drugs collaboration

Bizjournals.com

Sat, 03/18/17 - 09:28 am

Circassia snags a pair of asthma biotechs for $371M

Fierce Biotech

Fri, 05/15/15 - 09:51 am

Circassia looks to higher doses to salvage ragweed drug after PhIIb miss

Fierce Biotech

Mon, 12/8/14 - 03:52 pm

ragweed pollen allergy

Circassia Raises $333.5 Million in IPO for Allergy Shot

Bloomberg

Thu, 03/13/14 - 08:47 am

Circassia Plans $285 Million IPO to Fund Allergy Vaccines

Bloomberg

Thu, 02/6/14 - 10:18 am

Circassia to Sell Own Cat-Allergy Vaccine If Test Works

Bloomberg

Sat, 03/23/13 - 09:47 am

Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy, T-Cell Vaccine

Medical News Today

Sat, 02/13/10 - 11:32 am

Ragweed Allergy